ProMIS Neurosciences regains compliance with Nasdaq market value listing requirement

ProMIS Neurosciences Inc.

Received Nasdaq notice on July 22 confirming compliance with $35M minimum market value of listed securities.
Common shares traded above $35M market cap for 10 consecutive business days, July 8-19, 2024.
Matter is closed; company continues trading on Nasdaq Capital Market under ticker PMN.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.